Clinical value of plasma AT-Ⅲ and serum PCT, IL-6 levels and the evaluations of disease activity in Crohn's disease

Zhong-peng YIN,Ling-xiong SONG,Su-meng WANG,Jun-jun WANG,Feng WANG
DOI: https://doi.org/10.3969/j.issn.1672-271X.2018.01.005
2018-01-01
Abstract:Objective This study was undertaken to investigate the relationship between the levels of plasma AT-Ⅲ,serum IL-6,PCT and Crohns disease patients. The study explored their clinical significance from inflammatory cytokines and coagulation sys-tem,and evaluate the activity in Crohns disease. Methods The levels of AT-Ⅲ,IL-6 and PCT were tested in 62 Crohns disease patients which was divided into two groups. The correlation analyses were performed. Results The level of AT-Ⅲin Crohns disease patients was significantly lower than the level in healthy people[(70.1±15.12)% vs(84.5±13.2)%,P<0.01]. On the contrary,the levels of IL-6 and PCT in Crohns disease patients were significantly higher than the level in healthy people[73.55(26.6,113)ng/L vs 1.2(0.5,3.1)ng/L,0.64(0.15,3.37)μg/L vs 0.03(0.02,0.06)μg/L,P<0.01]. The level of AT-Ⅲin the activity group was signifi-cantly lower than the level in the remission group[(59.45±13.24)% vs(76.24±15.53)%,P<0.01],the level of IL-6 in the activity group was significantly higher than the level in the remission group[65.23(53.3,155.38)ng/L vs 29.66(20.5,59.35)ng/L,P<0.01], also the level of PCT in the activity group was significantly higher than the level in the remission group[8.4(2.6, 19.2)μg/L vs 0.29(0.13, 1.20)μg/L, P<0.05]. In Crohns disease patients active group, AT-III level significantly negatively correlates with IL-6 and PCT levels(r=-0.389,r=-0.317,P<0.01). AT-III level also significantly negatively correlates with IL-6 and PCT levels (r=-0.308,r=-0.279,P<0.05)in the remission group. Conclusion In Crohns disease patients,the level of AT-III is well-cor-related with IL-6 and PCT. The combined detection of plasma AT-III activity and the levels of serum IL-6 and PCT can contribute to early diagnosis of Crohn's disease and the judgement of the disease activity.
What problem does this paper attempt to address?